Targeting DNA-methylation Fingerprints Linked to Ultra-Processed Foods Consumption to Prevent Non-communicable Diseases: the METHYL-UP Study

Sponsor
IMDEA Alimentación (Other)
Overall Status
Recruiting
CT.gov ID
NCT05319327
Collaborator
(none)
106
1
2
42.8
2.5

Study Details

Study Description

Brief Summary

Non-communicable diseases (NCD) are the main health challenge in industrialized countries. However, these diseases are preventable if an intervention based on lifestyle is implemented at the population level. Diet has a great impact on the onset and progression of NCD. In this regard, ultra-processed food (UPF) consumption has been related to higher morbidity and mortality. UPF are defined as "formulations made mostly or entirely from substances derived from foods and additives, with little if any intact unprocessed or minimally processed foods" (NOVA definition). UPF are rich in saturated fats and additives and poor in fiber other nutrients. UPF consumption has raised in the last decades in the industrialized countries and this increase has been associated with higher prevalence of metabolic disorders such as diabetes, obesity, metabolic syndrome, cardiovascular disease, and cancer. However, mechanisms that link UPF consumption with NCD are poorly understood and clinical trials are needed to unravel these mechanisms and how to impact on them through lifestyle interventions. The investigators have previously identified DNA methylation marks associated with UPF consumption. DNA methylation marks are modifiable. The aim of the study is to assay if DNA methylation marks related to UPF consumption are reversible by reducing UPF consumption in a population of adults with overweight or obesity and with a high basal UPF consumption (>35% of total food consumption in g/day).

Condition or Disease Intervention/Treatment Phase
  • Other: Nutritional intervention
  • Other: Control
N/A

Detailed Description

The investigators propose a controlled, randomized, parallel groups intervention study based on nutritional counseling to reduce UPF consumption. Eligible participants are adults (18-50 years old), men and women, with overweight or obesity (BMI 25-40 Kg/m2) with a high basal consumption of UPF (>35% of total intake in g/day).

Recruited participants will be randomly allocated into a control group or an intervention group. Participants in the control group will be provided with nutritional guidelines to follow a healthy diet based on a Mediterranean diet. Participants in the intervention group will follow a nutritional intervention program aimed to reduce UPF consumption. Nutritional intervention will not modify basal caloric intake but will record energy intake along the intervention. Nutritional counseling will be based on nutritional educational material such as encourage and discourage food items, recipes, menus and food shopping lists based on unprocessed or minimally processed foods.

Total intervention will last 6 months for both groups. During the intervention phase, a monthly interview with nutritionist/dietitian is scheduled. Face-to-face interviews will be carried out in months 2 and 4. Phone interviews will be carried out in months 1, 3 and 5. In the baseline and final visits (months 0 and 6) a sample and data collection will be performed.

Data collected will include general socio-demographical data (age, sex, educational level, working status, civil status, rural/urban status), lifestyle data (smoking habits, dietary habits, physical activity, sleeping habits), anthropometric data (height, weight, waist circumference, body composition), and clinic-phenotypical parameters (blood pressure, medication, adverse effects, disease prevalence). Biological sample collection will include blood, urine, saliva and feces. Biochemical and blood cells parameters will be measured (blood cell count, glucose, lipid and hepatic profiles).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
106 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Controlled, randomized, parallel groups interventionControlled, randomized, parallel groups intervention
Masking:
Single (Investigator)
Masking Description:
The investigator who will analyze data will be provided with blinded data regarding the groups. Control and intervention groups will be randomly designated as group A and B. Investigator responsible for the analyses of the effect of the intervention on primary outcomes will compared groups A and B in a blinded manner.
Primary Purpose:
Prevention
Official Title:
Targeting DNA-methylation Fingerprints Linked to Ultra-Processed Foods Consumption to Prevent Non-communicable Diseases: the METHYL-UP Study
Actual Study Start Date :
Jun 6, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control Group

Participants in the control group will be provided with nutritional guidelines to follow a healthy diet based on a Mediterranean diet.

Other: Control
General counseling to adhere to a healthy Mediterranean diet

Experimental: Intervention group

Participants in the intervention group will follow a nutritional intervention program aimed to reduce UPF consumption. Nutritional intervention will not modify basal caloric intake but will record energy intake along the intervention. Nutritional counseling will be based on nutritional educational material such as encouraged and discouraged food items, recipes, menus and food shopping lists based on unprocessed or minimally processed foods.

Other: Nutritional intervention
A nutritional intervention program aimed to reduce UPF consumption. Nutritional intervention will not modify basal caloric intake but will record energy intake along the intervention. Nutritional counseling will be based on nutritional educational material such as encouraged and discouraged food items, recipes, menus and food shopping lists based on unprocessed or minimally processed foods. Total intervention will last 6 months for both groups. During the intervention phase, a monthly interview with nutritionist/dietitian is scheduled. Face-to-face interviews will be carried out in months 2 and 4. Phone interviews will be carried out in months 1, 3 and 5. In the baseline and final visits (months 0 and 6) a sample and data collection will be performed.
Other Names:
  • Reduction of UPF consumption
  • Outcome Measures

    Primary Outcome Measures

    1. UPF [6 months]

      Ultra-processed food consumption

    Secondary Outcome Measures

    1. Weight [6 months]

      Weight change (Kg)

    2. BMI [6 months]

      Change in body mass index (Kg/m2)

    3. Obesity [6 months]

      Percentage of participants who reverse obesity condition (BMI < 30 Kg/m2)

    4. Body composition [6 months]

      Change in % of fat mass

    Other Outcome Measures

    1. DNA methylation [12 months]

      Reversibility of DNA methylation marks

    2. Glucose [9 months]

      Change in fastin glucose levels (mg/dL)

    3. Glycated haemoglobin [9 months]

      Change in fastin glycated haemoglobin levels (%)

    4. Triglycerides [9 months]

      Change in fasting triglycerides levels (mg/dL)

    5. LDL-cholesterol [9 months]

      Change in fasting LDL-cholesterol levels (mg/dL)

    6. HDL-cholesterol [9 months]

      Change in fasting HDL-cholesterol levels (mg/dL)

    7. Liver profile [9 months]

      Change in HSI liver function index

    8. Microbiota [24 months]

      Changein microbiota diversity

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Men/women

    • 18-50 years old

    • BMI 25-40 Kg/m2

    • UPF consumption > 35% of total intake in g/day

    Exclusion Criteria:
    • Pregnancy

    • Menopause

    • IMC <25 Kg/m2 or > 40 Kg/m2

    • Excessive alcohol consumption

    • Prevalent cardiovascular, renal, lung, pancreatic or liver disease

    • Type 1 diabetes

    • Type 2 diabetes with poor glucose control or unstable medication during last 3 months

    • Prevalent endocrine disease

    • Changes in anti-hypertensive medication during last 3 months

    • Insulin, systemic anti-inflammatory, or glucocorticoid medication during last 3 months

    • Food allergies or intolerances

    • Psychosocial or cultural factors that prevent from following the intervention

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 IMDEA Food Madrid Spain 28049

    Sponsors and Collaborators

    • IMDEA Alimentación

    Investigators

    • Study Director: José M Ordovás, PhD, Fundación IMDEA Alimentación

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Dra. Lidia Daimiel Ruiz, Senior Researcher, IMDEA Alimentación
    ClinicalTrials.gov Identifier:
    NCT05319327
    Other Study ID Numbers:
    • IMD: PI-048
    First Posted:
    Apr 8, 2022
    Last Update Posted:
    Apr 8, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Dra. Lidia Daimiel Ruiz, Senior Researcher, IMDEA Alimentación
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 8, 2022